Pekin Hardy Strauss’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$648K Buy
704
+23
+3% +$23.3K 0.07% 270
2025
Q4
$732K Sell
681
-13
-2% -$12.4K 0.07% 231
2025
Q3
$530K Buy
694
+50
+8% +$37.2K 0.05% 245
2025
Q2
$502K Buy
644
+15
+2% +$11.7K 0.06% 244
2025
Q1
$519K Sell
629
-59
-9% -$49.1K 0.06% 241
2024
Q4
$531K Sell
688
-848
-55% -$702K 0.07% 240
2024
Q3
$1.36M Buy
1,536
+180
+13% +$162K 0.17% 123
2024
Q2
$1.23M Buy
1,356
+130
+11% +$104K 0.17% 129
2024
Q1
$954K Sell
1,226
-64
-5% -$45.5K 0.13% 145
2023
Q4
$752K Buy
1,290
+13
+1% +$7.59K 0.11% 162
2023
Q3
$686K Buy
1,277
+200
+19% +$103K 0.11% 164
2023
Q2
$505K Buy
1,077
+254
+31% +$107K 0.06% 195
2023
Q1
$283K Sell
823
-300
-27% -$101K 0.04% 245
2022
Q4
$411K Buy
1,123
+10
+0.9% +$3.55K 0.06% 209
2022
Q3
$360K Buy
1,113
+43
+4% +$13.6K 0.06% 215
2022
Q2
$347K Buy
1,070
+68
+7% +$20.4K 0.05% 230
2022
Q1
$287K Hold
1,002
0.04% 278
2021
Q4
$277K Sell
1,002
-100
-9% -$25.4K 0.04% 284
2021
Q3
$255K Buy
1,102
+100
+10% +$24.7K 0.04% 286
2021
Q2
$230K Buy
+1,002
New +$201K 0.03% 287
2015
Q3
Sell
-2,570
Closed -$215K 168
2015
Q2
$215K Buy
+2,570
New +$196K 0.04% 146

Other funds holding LLY

Pekin Hardy Strauss's LLY Position: Q1 2026 in Review

Pekin Hardy Strauss increased its Eli Lilly (LLY) stake by 3.4% in Q1 2026, buying an estimated $23.3K and bringing the position to 704 shares worth $648K. The position accounts for 0.07% of the portfolio, ranked #270.

Pekin Hardy Strauss first reported a position in LLY in Q2 2015 and has held it in 21 quarters since. The position peaked at $1.36M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Pekin Hardy Strauss held 704 shares of Eli Lilly worth $648K as of Q1 2026.
  • Pekin Hardy Strauss bought 23 Eli Lilly shares in Q1 2026, an estimated $23.3K.
  • Eli Lilly made up 0.07% of Pekin Hardy Strauss's portfolio in Q1 2026, its #270 holding.
  • Pekin Hardy Strauss first reported a position in Eli Lilly in Q2 2015 and has held it in 21 quarters since.
  • Pekin Hardy Strauss's Eli Lilly position peaked at $1.36M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Pekin Hardy Strauss's 13F filing for Q1 2026, filed 7 May 2026.